These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10937729)

  • 1. 5-Alkyltryptamine derivatives as highly selective and potent 5-HT1D receptor agonists.
    Slassi A; Edwards L; O'Brien A; Meng CQ; Xin T; Seto C; Lee DK; MacLean N; Hynd D; Chen C; Wang H; Kamboj R; Rakhit S
    Bioorg Med Chem Lett; 2000 Aug; 10(15):1707-9. PubMed ID: 10937729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer-aided design and synthesis of 5-substituted tryptamines and their pharmacology at the 5-HT1D receptor: discovery of compounds with potential anti-migraine properties.
    Glen RC; Martin GR; Hill AP; Hyde RM; Woollard PM; Salmon JA; Buckingham J; Robertson AD
    J Med Chem; 1995 Sep; 38(18):3566-80. PubMed ID: 7658443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and serotonergic activity of arylpiperazide derivatives of serotonin: potent agonists for 5-HT1D receptors.
    Perez M; Fourrier C; Sigogneau I; Pauwels PJ; Palmier C; John GW; Valentin JP; Halazy S
    J Med Chem; 1995 Sep; 38(18):3602-7. PubMed ID: 7658447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the endothelium and nitric oxide on the contractile responses evoked by 5-HT1D receptor agonists in the rabbit isolated saphenous vein.
    Valentin JP; Bonnafous R; John GW
    Br J Pharmacol; 1996 Sep; 119(1):35-42. PubMed ID: 8872354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and serotonergic activity of 5-(oxadiazolyl)tryptamines: potent agonists for 5-HT1D receptors.
    Street LJ; Baker R; Castro JL; Chambers MS; Guiblin AR; Hobbs SC; Matassa VG; Reeve AJ; Beer MS; Middlemiss DN
    J Med Chem; 1993 May; 36(11):1529-38. PubMed ID: 8496922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Methyl-5-tert-butyltryptamine: A novel, highly potent 5-HT1D receptor agonist.
    Xu YC; Schaus JM; Walker C; Krushinski J; Adham N; Zgombick JM; Liang SX; Kohlman DT; Audia JE
    J Med Chem; 1999 Feb; 42(3):526-31. PubMed ID: 9986723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological activity of 3-[2-(dimethylamino)ethyl]-5-[(1,1-dioxo-5-methyl-1,2,5-thiadiazolidin- 2-yl)-methyl]-1H-indole and analogues: agonists for the 5-HT1D receptor.
    Castro JL; Baker R; Guiblin AR; Hobbs SC; Jenkins MR; Russell MG; Beer MS; Stanton JA; Scholey K; Hargreaves RJ
    J Med Chem; 1994 Sep; 37(19):3023-32. PubMed ID: 7932524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-(Sulfonyl)oxy-tryptamines and ethylamino side chain restricted derivatives. Structure-affinity relationships for h5-HT1B and h5-HT1D receptors.
    Barf T; Wikström H; Pauwels PJ; Palmier C; Tardif S; Lundmark M; Sundell S
    Bioorg Med Chem; 1998 Sep; 6(9):1469-79. PubMed ID: 9801818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzylimidazolines as h5-HT1B/1D serotonin receptor ligands: a structure-affinity investigation.
    Law H; Dukat M; Teitler M; Lee DK; Mazzocco L; Kamboj R; Rampersad V; Prisinzano T; Glennon RA
    J Med Chem; 1998 Jun; 41(13):2243-51. PubMed ID: 9632357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine.
    John GW; Pauwels PJ; Perez M; Halazy S; Le Grand B; Verscheure Y; Valentin JP; Palmier C; Wurch T; Chopin P; Marien M; Kleven MS; Koek W; Assie MB; Carilla-Durand E; Tarayre JP; Colpaert FC
    J Pharmacol Exp Ther; 1999 Jul; 290(1):83-95. PubMed ID: 10381763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]L-694,247 labels the 5-HT1D beta receptor in pig caudate membranes.
    Heald A; Stanton JA; Osborne SA; Middlemiss DN; Beer MS
    Eur J Pharmacol; 1994 Oct; 264(2):213-6. PubMed ID: 7851485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for presynaptic location of inhibitory 5-HT1D beta-like autoreceptors in the guinea-pig brain cortex.
    Bühlen M; Fink K; Böing C; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):281-9. PubMed ID: 8692282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-694,247: a potent 5-HT1D receptor agonist.
    Beer MS; Stanton JA; Bevan Y; Heald A; Reeve AJ; Street LJ; Matassa VG; Hargreaves RJ; Middlemiss DN
    Br J Pharmacol; 1993 Nov; 110(3):1196-200. PubMed ID: 8298808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
    Ellwood AJ; Curtis MJ
    Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of O-alkyl derivatives of serotonin at human 5-HT1D beta receptors.
    Glennon RA; Hong SS; Bondarev M; Law H; Dukat M; Rakhi S; Power P; Fan E; Kinneau D; Kamboj R; Teitler M; Herrick-Davis K; Smith C
    J Med Chem; 1996 Jan; 39(1):314-22. PubMed ID: 8568822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Thienyltryptamine derivatives as serotonin 5-HT1B/1D receptor agonists: potential treatments for migraine.
    Meng CQ; Rakhit S; Lee DK; Kamboj R; McCallum KL; Mazzocco L; Dyne K; Slassi A
    Bioorg Med Chem Lett; 2000 May; 10(9):903-5. PubMed ID: 10853656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT(1B/1D/2) receptor antagonist properties.
    Pullar IA; Boot JR; Carney SL; Cohen ML; Colvin EM; Conway RG; Hardy CH; Lucaites VL; Nelson DL; Schenck KW; Tomlinson R; Wedley S
    Eur J Pharmacol; 2001 Nov; 432(1):9-17. PubMed ID: 11734182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New selective and potent 5-HT(1B/1D) antagonists: chemistry and pharmacological evaluation of N-piperazinylphenyl biphenylcarboxamides and biphenylsulfonamides.
    Liao Y; Böttcher H; Harting J; Greiner H; van Amsterdam C; Cremers T; Sundell S; März J; Rautenberg W; Wikström H
    J Med Chem; 2000 Feb; 43(3):517-25. PubMed ID: 10669578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines.
    Perrone R; Berardi F; Colabufo NA; Leopoldo M; Lacivita E; Tortorella V; Leonardi A; Poggesi E; Testa R
    J Med Chem; 2001 Dec; 44(25):4431-42. PubMed ID: 11728188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-[3-(2-Dimethylaminoethyl)-2-methyl-1H- indol-5-yl]-4-fluorobenzamide: a potent, selective, and orally active 5-HT(1F) receptor agonist potentially useful for migraine therapy.
    Xu YC; Johnson KW; Phebus LA; Cohen M; Nelson DL; Schenck K; Walker CD; Fritz JE; Kaldor SW; LeTourneau ME; Murff RE; Zgombick JM; Calligaro DO; Audia JE; Schaus JM
    J Med Chem; 2001 Nov; 44(24):4031-4. PubMed ID: 11708905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.